Table 7. Multivariate Cox proportional hazards analysis of survival factors in the F2 comparison group.
| Characteristic | HR | 95% CI | p-value |
|---|---|---|---|
| Age_at_diagnosis | 1.01 | 1.00, 1.02 | 0.14 |
| Gender | |||
| Female | — | — | |
| Male | 1.12 | 0.96, 1.31 | 0.14 |
| Race_new | |||
| White | — | — | |
| Black or African American | 1.11 | 0.81, 1.50 | 0.5 |
| Other | 0.89 | 0.68, 1.16 | 0.4 |
| Stage | |||
| Stage I | — | — | |
| Stage II | 1.4 | 1.15, 1.71 | <0.001 |
| Stage III | 1.85 | 1.51, 2.25 | <0.001 |
| Stage IV | 1.4 | 1.06, 1.86 | 0.02 |
| Tissue_or_organ_of_origin | |||
| Lower lobe, lung | — | — | |
| Lung, NOS | 1.13 | 0.72, 1.77 | 0.6 |
| Middle lobe, lung | 1.69 | 1.12, 2.56 | 0.013 |
| Pleura, NOS | 1.77 | 1.41, 2.23 | <0.001 |
| Upper lobe, lung | 1.3 | 1.08, 1.56 | 0.006 |
| Treatment_type2 | |||
| Chemotherapy | — | — | |
| Ancillary Treatment | 1.17 | 0.63, 2.18 | 0.6 |
| Immunotherapy (Including Vaccines) | 2.17 | 0.80, 5.91 | 0.13 |
| Pleurodesis, NOS | 1.05 | 0.76, 1.44 | 0.8 |
| Radiation | 1.09 | 0.91, 1.29 | 0.4 |
| Targeted Therapy | 1.05 | 0.86, 1.27 | 0.7 |
| Laterality | |||
| Left | — | — | |
| Right | 1.16 | 1.00, 1.35 | 0.047 |
| Counts_F2 | 1.16 | 1.10, 1.23 | <0.001 |
Survival analysis of F2 in comparison group (Multivariable).